Trypanosoma cruzi

Commercial enzyme-linked immunosorbent assay versuspolymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis

Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis

Identification of a type I nitroreductase gene in non-virulent Trypanosoma rangeli

Sexual transmission of American trypanosomiasis in humans: a new potential pandemic route for Chagas parasites

Chagas disease: national survey of seroprevalence in children under five years of age conducted in 2008

Linalool, a Piper aduncum essential oil component, has selective activity against Trypanosoma cruzi trypomastigote forms at 4°C

Prevalence of Trypanosoma cruzi infection among Bolivian immigrants in the city of São Paulo, Brazil

The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi

Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations

Subcellular localisation of FLAG tagged enzymes of the dynamic protein S-palmitoylation cycle of Trypanosoma cruzi epimastigotes

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil

Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi

Trypanosoma cruzi strain TcIV infects raccoons from Illinois

Can sexual transmission support the enzootic cycle of Trypanosoma cruzi?

Extracellular vesicles isolated from Trypanosoma cruzi affect early parasite migration in the gut of Rhodnius prolixus but not in Triatoma infestans

Trypanosoma cruzi down-regulates mechanosensitive proteins in cardiomyocytes

Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites

Heparan sulfate proteoglycan triggers focal adhesion kinase signaling during Trypanosoma cruzi invasion

Application of WHO International Biological Reference Standards to evaluate commercial serological tests for chronic Chagas disease

Role of Trypanosoma cruzi nucleoside diphosphate kinase 1 in DNA damage responses

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection

A new Trypanosoma cruzi genotyping method enables high resolution evolutionary analyses

Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG

Genomics and functional genomics in Leishmania and Trypanosoma cruzi: statuses, challenges and perspectives

Genetic diversity of Trypanosoma cruzi strains isolated from chronic chagasic patients and non-human hosts in the state of São Paulo, Brazil

Chagas disease affects the human placental barrier’s turnover dynamics during pregnancy

Genomic surveillance: a potential shortcut for effective Chagas disease management

Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment

Perspectives for a new drug candidate for Chagas disease therapy

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy

Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory

The translational challenge in Chagas disease drug development

Significance of a neglected tropical disease: lessons from a paradigmatic case of ‘success in translation’

Predictors of Trypanosoma cruzi PCR positivity in patients with chronic Chagas disease

Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells

Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease

Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites

Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models

Trypanosomatid research in Brazil: a systematic analysis of regional and temporal trends

In vitro and in vivo studies on the activity and selectivity of butoconazole in experimental infection by Trypanosoma cruzi

Influence of a hyperglycaemic diet on Trypanosoma cruzi infection in mice model

Breaking the ice − simplified freeze-fracture of parasitic protists: a cost-effective approach without highly specialised equipment

Diagnosis of Trypanosoma cruzi infection in Mexican populations: current conventional serology lacks adequate sensitivity and specificity

The impact of probiotic administration on experimental in vitro and in vivo infection by Trypanosoma cruzi

Phospholipids and phospholipase A1 as antigens during the course of experimental Trypanosoma cruzi infection

Acute Chagas disease in Amazonia, western Pará: perspectives from medical assistance to genetic elucidation

The 50th Anniversary Conference − Caxambu 2024

Beyond the first case of Chagas disease: the Berenice strain as a model for understanding long-term Trypanosoma cruzi infection

Chagas, a lógica e a descoberta

Inscrever-se em Trypanosoma cruzi